- Home
- MCBS vs MPLT Comparison
MCBS vs MPLT Comparison
Compare MCBS & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCBS | MPLT |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 816.1M | 811.3M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MCBS | MPLT |
|---|---|---|
| Price | $29.01 | $21.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $32.00 | $31.80 |
| AVG Volume (30 Days) | 99.4K | ★ 185.5K |
| Earning Date | 04-17-2026 | 03-26-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 4.76 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.78 | N/A |
| Revenue Next Year | $4.83 | N/A |
| P/E Ratio | $11.03 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.24 | $12.24 |
| 52 Week High | $31.00 | $21.55 |
Technical Indicators
Market Signals| Indicator | MCBS | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 59.33 | 65.04 |
| Support Level | $28.40 | $16.19 |
| Resistance Level | $30.38 | N/A |
| Average True Range (ATR) | 0.70 | 1.55 |
| MACD | 0.10 | 0.32 |
| Stochastic Oscillator | 87.56 | 87.97 |
Price Performance
Historical ComparisonAbout MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.